Nationality: German | Year of birth: 1966
Dr. Lutz Hegemann is President of Global Health and Swiss Country Affairs. The Global Health unit focuses on transforming healthcare in low- and middle-income countries by broadening inclusive access to innovative medicines. Under his leadership, Novartis Global Health drives programs targeting malaria, neglected tropical diseases, and non-communicable diseases such as sickle cell disease and cardiovascular disease. He also oversees Novartis’ presence in sub-Saharan Africa. Lutz also represents the company both at home in Switzerland and internationally, building strategic partnerships across public and private sectors to advance inclusive global health innovation.
Reimagining medicine means reimagining access. At Novartis, we maximize our positive impact as a sustainable business through our consistent efforts to enable broad and inclusive access to our innovation, regardless of where patients live.
Lutz joined Novartis in 2005 in the Consumer Health Division and has held roles across Research & Development, Commercialization, General Management, and Corporate Affairs. He began his career as a public health physician and scientist.
Lutz is a Fellow of the Royal Society for Tropical Medicine & Hygiene and serves on several boards, including the Swiss Tropical and Public Health Institute and PATH.
